investingreview.org logo
Vermeiden Sie Betrug, informieren Sie sich und finden Sie das Beste
Nothings Found.

Hold Tight! Changes in Ashford Capital Management Inc's Q3 2022 vs. Q4 2022 13F Holdings

Ava Hoppe | 24 April, 2023

Ashford Capital Management Inc, an investment management firm, recently reported its Q3 2022 and Q4 2022 13F holdings to the SEC. The report revealed that the firm made significant changes in its holdings during the period. In this blog post, we will examine those changes and their potential implications.

Introduction

In an economy in which the stock market is booming and more people are investing, investment management firms are becoming more vital. A prime example of such a firm is Ashford Capital Management Inc, which manages over $800 million in assets. The firm recently released its Q3 2022 and Q4 2022 13F holdings, which showed interesting changes.

Main Body

During Q4 2022, Ashford Capital Management Inc purchased 5.5% more shares of Incyte Corporation (INCY), a pharmaceutical company, exceeding 452,048 shares. This increase was also significant in the value of shares, which almost reached $36,000, an increase of 26%. Another pharmaceutical-related notable stock was Supernus Pharmaceuticals Inc. (SUPN). Ashford reduced its holdings of SUPN, decreasing the number of shares by a significant 14.7%. There was a corresponding decrease in value from $37,047 to $33,310, a move that could reflect Ashford's concerns about the company's future.

Axon Enterprise (AXON), a technology services company, saw its shares decline in value by 6.7% in Q4 2022, but it still witnessed an increase in the number of shares held by Ashford. The firm sold off some of its shares of Red Violet Inc (RDVT), an analytics company for risk assessment and investigation services, reducing its holdings of RDVT shares by 4.7% in Q4 2022.

One of the significant increases in Ashford Capital Management Inc's Q4 2022 holdings was seen in MarketAxess Holdings Inc (MKTX), a company that operates an electronic trading platform for fixed-income securities. Ashford Capital Management Inc acquired almost 11.1% more shares of the company. In Q3 2022, the number of shares held was just 94,549; however, the number of shares held tripled in Q4 2022, reaching 104,746. MKTX stock also had a significant increase in value from $21,036 to $29,212, a jump of nearly 38.9%.

Another notable stock was CoStar Group Inc (CSGP), a commercial real estate information, analytics, and online marketplace. Ashford Capital Management Inc acquired over 10.8% more shares of CSGP in Q4 2022, raising its holdings to 358,789 shares. CSGP's value also increased from $22,733 to $27,727, an increase of approximately 22%.

Conclusion

From Ashford Capital Management Inc's Q3 2022 vs. Q4 2022 13F holdings comparison, it is evident that the firm made significant changes across a range of holdings. The company demonstrated a willingness to invest and divest in specific sectors. Ashford Capital Management Inc's shift into technology stocks like MarketAxess Holdings Inc (MKTX) and Axon Enterprise (AXON) reflects optimism towards the future of that sector. While the reasons behind other changes in the company's holdings are less apparent, it is clear that the firm has confidence in some stocks' future growth while paring back on others.

Viele Menschen wurden durch Betrug und Ponzi-Vorhaben verbrannt. Deshalb haben wir diese Website erstellt, um Ihnen als potenziellem Investor dabei zu helfen, die Fakten zu ermitteln, die besten zu finden und Betrugs- und Ponzi-Vorhaben zu vermeiden.

Alle auf dieser Website bereitgestellten Informationen werden ohne Gewähr und nur zu Informationszwecken bereitgestellt.
InvestingReview.org bietet keine Anlageberatung an. InvestingReview.org ist kein Anlageberater und wird von keiner US-amerikanischen oder nicht US-amerikanischen Aufsichtsbehörde unterstützt oder ist mit dieser verbunden.


Kürzlich gesuchte Firmen

Bitte beachten Sie: Die Suchdaten werden von Dritten gesammelt und einmal täglich aktualisiert.

Copyright © 2023 by InvestingReview.org / Alle Rechte vorbehalten.